What are you looking for?

Utilizing Data and Key Performance Indicators to Successfully Execute a Phase III Influenza Treatment Clinical Trial

July 04, 2016
Download Now

SGS was engaged in a global Phase III influenza treatment clinical trial, providing both overall project management and study monitoring. The trial was one of the largest influenza treatment trials conducted to date, and as a result presented several challenges, due in part to the seasonality of influenza and the geographic imbalance in the outbreaks. This paper will address how SGS utilized constant data tracking to mitigate the disease-specific challenges and successfully execute this Phase III clinical trial.

 

 

SGS LSS

Please complete the form to download your copy.

    News & Insights

    • SGS Headquarters

    1 Place des Alpes,

    P.O. Box 2152 1211,

    Geneva Switzerland